A military whistleblower released a series of documents revealing that the military began “liberally” administering remdesivir to service members who were suspected of having COVID-19 — months before the FDA approved the drug.

A military whistleblower released a series of documents revealing 601 deaths of military service members and a high rate of serious adverse events in clinical trials involving remdesivir, an antiviral commonly administered to COVID-19 patients during the pandemic.

“Data derived from the Department of Defense [DOD] Joint Trauma System … by a military whistleblower offers a stark contrast to results of multiple clinical trials involving the liberal usage of remdesivir in military treatment facilities and other civilian facilities, as well as its potential contribution to, at minimum, hundreds of untimely deaths,” the documents state.

“All of the information here needs to be made public and the public officials, including Tony Fauci, need to be held to account for the criminal acts associated with the fraudulent ‘trials’ of ivermectin and hydroxychloroquine that were tainted in order to preclude their use, and making remdesivir the standard of care despite the obvious data showing that it kills people.”

Former victims of the COVID-19 hospital protocols, which included administration of remdesivir, and advocates for those victims welcomed the documents’ release.

https://childrenshealthdefense.org/defender/remdesivir-papers-drug-military-members-941-deaths/?